NCT04948216

Brief Summary

During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2020

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 1, 2021

Completed
Last Updated

July 6, 2021

Status Verified

July 1, 2021

Enrollment Period

15 days

First QC Date

June 29, 2021

Last Update Submit

July 2, 2021

Conditions

Pulmonary Disease, Chronic ObstructiveAsthma

Outcome Measures

Primary Outcomes (2)

  • Respiratory symptoms

    COPD Assessment Test (CAT)

    through study completion, an average of 2 week.

  • Frequency of exacerbation during the COVID-19 epidemic

    Frequency of exacerbation during the COVID-19 epidemic

    through study completion, an average of 2 week.

Interventions

No interventionOTHER

No intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients in the database were involved.

You may qualify if:

  • COPD patients and asthma patients in the Chronic Airway Disease Database in Peking University Third Hospital.

You may not qualify if:

  • Refusal to participate in this study; cognitive dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveAsthma

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchial DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Yongchang Sun, M.D.

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Respiratory and Critical Care Medicine

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 1, 2021

Study Start

April 28, 2020

Primary Completion

May 13, 2020

Study Completion

May 13, 2020

Last Updated

July 6, 2021

Record last verified: 2021-07

Locations

CN(1)